• 1
    Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132:112117.
  • 2
    Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 11:7480.
  • 3
    Ground KEV. Prevalence of fatty liver in healthy adults accidentally killed. Aviat Space Environ Med 1984; 55:5961.
  • 4
    Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55:434438.
  • 5
    Bacon BR, Farahvash MJ, Janney CG, Neuschwander Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107:11031109.
  • 6
    Diehl AM, Goodman Z, Ishak KG. Alcoholic liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95:10561062.
  • 7
    Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11:7480.
  • 8
    Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116:14131419.
  • 9
    Prati D, Taioli E, Zanella A, Della TE, Butelli S, Del Vecchio E, Vianello L, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137:110.
  • 10
    Contos MJ, Cales W, Luketic VA, Sterling RK, Shiffman ML, Mills AS, Fisher RA, et al. Development of nonalcoholic fatty liver disease after liver transplant for cryptogenic cirrhosis. Liver Transpl 2001; 7:363373.
  • 11
    Brunt EM, Janney CG, Di Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:24672474.
    Direct Link:
  • 12
    National Institutes of Health. Third report of the national cholesterol education program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III). NIH Publication 2001:13670.
  • 13
    National Institutes of Health. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998; 158:18551867.
  • 14
    Karmen A, Wroblewski F, LaDue JS. Transaminase activity in human blood. J Clin Invest 1955; 34:126133.
  • 15
    Kallei L, Hahn A, Roder VZ. Correlation between histological findings and serum transaminase values in chronic diseases of the liver. Acta Med Scand 1964; 175:4956.
  • 16
    Kaplan MM. Alanine aminotransferase levels: what's normal? Ann Intern Med 2002; 137:4951.
  • 17
    Alberti A, Morsica G, Chemello L. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340:697.